Shikoku Kasei Holdings CorpolationSHIKOKU KASEI HOLDINGS CORPOLATION4099東証プライム化学FY ending Dec 2025, consolidated, J-GAAP
About 73% of Shikoku Kasei Holdings Corpolation's sales come from Chemical products, with Building materials and Other making up much of the rest.
Out of every ¥100 of sales, about ¥15 is left as operating profit.
Revenue changed +1.7% from the prior year, operating profit +11.6%.
Revenue +1.7% · profit +11.6%, calculated from disclosed figures.
Operating leverage: 6.64× (profit growth ÷ revenue growth)
FY ending Dec 2024 → FY ending Dec 2025
FY ending Dec 2024 → FY ending Dec 2025
For every ¥100 Shikoku Kasei Holdings Corpolation sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
訂正有価証券報告書-第106期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第105期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第104期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第103期(2022/04/01-2022/12/31)
Extracted from XBRL: 53 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.